Champions Oncology develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The Company provides Personalized Oncology Solutions that assist physicians in developing personalized treatment options for cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services.
Type | Public | |
Founded | 2007 | |
HQ | Hackensack, NJ, US | Map |
Website | championsoncology.com | |
Employee Ratings | More | |
Overall Culture | A- | More |
USD | |
---|---|
Revenue (Q2, 2021) | 10.1m |
Gross profit (Q2, 2021) | 4.5m |
Gross profit margin (Q2, 2021), % | 44.2% |
Net income (Q2, 2021) | 1.0k |
EBIT (Q2, 2021) | 7.0k |
Market capitalization (19-Jan-2021) | 154.1m |
Closing stock price (19-Jan-2021) | 11.5 |
Cash (31-Oct-2020) | 8.6m |
EV | 152.1m |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.6m | 1.7m | 2.4m | 2.1m | 1.5m | 2.9m | 3.0m | 2.4m | 3.7m | 1.9m | 1.9m | 1.8m | 2.8m | 3.0m | 2.6m | 3.7m | 4.5m | 3.6m | 5.0m | 5.2m | 5.1m | 6.2m | 6.7m | 6.4m | 6.7m | 7.6m | 9.0m | 9.5m | 10.1m |
Cost of goods sold | 3.1m | 3.5m | 3.4m | 3.8m | 3.9m | 4.3m | 5.3m | 5.6m | |||||||||||||||||||||
Gross profit | 3.1m | 3.2m | 3.0m | 3.0m | 3.7m | 4.7m | 4.2m | 4.5m | |||||||||||||||||||||
Gross profit Margin, % | 50% | 48% | 47% | 44% | 49% | 52% | 44% | 44% |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 8.8m | 7.1m | 6.5m | 2.9m | 2.2m | 10.8m | 7.4m | 7.6m | 5.8m | 3.1m | 575.0k | 182.0k | 6.8m | 4.2m | 3.3m | 4.5m | 4.3m | 3.5m | 400.0k | 700.0k | 1.1m | 1.0m | 2.0m | 3.3m | 2.2m | 2.8m | 3.3m | 6.9m | 8.6m |
Accounts Receivable | 1.2m | 832.0k | 497.0k | 639.0k | 627.0k | 642.0k | 1.8m | 1.5m | 3.1m | 925.0k | 1.1m | 1.1m | 1.5m | 1.9m | 2.1m | 1.6m | 1.9m | 2.0m | 2.7m | 2.6m | 2.9m | 3.8m | 4.7m | 3.9m | 3.9m | 3.9m | 4.5m | 5.0m | 6.0m |
Prepaid Expenses | 341.0k | 328.0k | 110.0k | 208.0k | 95.0k | 300.0k | 255.0k | 219.0k | 281.0k | 456.0k | 393.0k | 258.0k | 366.0k | 295.0k | 414.0k | 349.0k | 445.0k | 541.0k | 360.0k | 303.0k | 185.0k | 246.0k | 262.0k | 298.0k | 256.0k | 363.0k | 355.0k | 360.0k | 477.0k |
Current Assets | 10.9m | 8.8m | 7.6m | 3.8m | 2.9m | 11.7m | 9.4m | 9.3m | 9.2m | 4.4m | 2.1m | 1.5m | 8.6m | 6.3m | 5.8m | 6.4m | 6.7m | 6.1m | 3.5m | 3.5m | 4.2m | 5.0m | 6.9m | 7.5m | 6.3m | 7.1m | 8.1m | 12.3m | 15.0m |
USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (8.7m) | (6.3m) | (7.4m) | (13.1m) | (10.4m) | (1.5m) | 128.0k | (2.0m) | |
Depreciation and Amortization | 105.0k | 203.0k | 213.0k | 214.0k | 156.0k | 168.0k | 360.0k | 606.0k | 825.0k |
Accounts Payable | 96.0k | (472.0k) | (223.0k) | 433.0k | 482.0k | (43.0k) | 301.0k | 653.0k | 333.0k |
Cash From Operating Activities | (5.2m) | (4.3m) | (3.4m) | (9.6m) | (6.5m) | (2.8m) | (1.2m) | 1.9m | 2.9m |
USD | Q1, 2012 |
---|---|
Financial Leverage | -11.9 x |
Champions Oncology has 366 Twitter Followers. The number of followers has increased 0.3% month over month and decreased 0.1% quarter over quarter
A-
86/100
A-
80/100
A+
100/100
When was Champions Oncology founded?
Champions Oncology was founded in 2007.
Who are Champions Oncology key executives?
Champions Oncology's key executives are Ronnie Morris, Philip Breitfeld and David Miller.
How many employees does Champions Oncology have?
Champions Oncology has 115 employees.
What is Champions Oncology revenue?
Latest Champions Oncology annual revenue is $32.1 m.
What is Champions Oncology revenue per employee?
Latest Champions Oncology revenue per employee is $279.3 k.
Who are Champions Oncology competitors?
Competitors of Champions Oncology include Gene Techno Science, Rgenta and Rubicon Biotechnology.
Where is Champions Oncology headquarters?
Champions Oncology headquarters is located at 1 University Plaza Dr #307, Hackensack.
Where are Champions Oncology offices?
Champions Oncology has offices in Hackensack, Rockville and London.
How many offices does Champions Oncology have?
Champions Oncology has 3 offices.
Receive alerts for 300+ data fields across thousands of companies